Skip to content

Clinical Assessment of a Customized Free-form Progressive Addition Lens Spectacle

Clinical Assessment of a Customized Free-form Progressive Addition Lens Spectacle

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01234207
Acronym
CZV_PAL1
Enrollment
95
Registered
2010-11-04
Start date
2009-02-28
Completion date
2009-10-31
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Presbyopia

Keywords

Progressive addition lenses, Customized free-form, Presbyopia, Bifocals, Subjective assessment, Visual performance, Visual acuity, Amsler grid

Brief summary

The purpose of this study was to compare objective clinical measures of visual performance and subjective measures of satisfaction and preference between standard progressive addition lens (PAL) spectacles and a new type of free-form surfaced, optically customized PAL spectacle.

Detailed description

In a double-masked crossover trial, 95 experienced wearers wore customized free-form PAL spectacles (Test) and standard non-free-form PAL spectacles (Control) for one week each. All subjects wore both Test and Control spectacles, and the pair to be worn first was randomly assigned. At dispensing and after 1 week of wear, subjects were tested for distance and near visual acuity (VA) under both high and low contrast; in addition, 30 degree off-axis VA was measured using a novel apparatus, as was the horizontal extent of undistorted vision at reading distance. Subjects also completed a set of questionnaires detailing their satisfaction levels, adaptation times, and preferences for Test or Control spectacles for different visual tasks.

Interventions

DEVICEStandard, non-free-form, non-customized PAL spectacles

Control spectacles include several different PAL brands as selected by patients in the UC Berkeley Optometry Clinic and purchased in the Eyewear Center; after successful fitting and purchase, potential subjects were recruited for the trial.

DEVICEIndividually customized free-form surfaced PAL spectacles

Test spectacles are Zeiss Individual, free-form surfaced, and customized using the iTerminal device to account for individual back vertex distance, wrap angle and pantoscopic tilt

Sponsors

Carl Zeiss Meditec, Inc.
CollaboratorINDUSTRY
University of California, Berkeley
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
39 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Presbyope * Experienced PAL spectacle wearer * Correctable to at least 20/25 in both eyes * Able and willing to use Test and Control spectacles for 1 week each as primary form of presbyopia correction * Able and willing to complete all laboratory measurements and questionnaire batteries

Exclusion criteria

* Purchasing free-form PAL spectacles from the UC Berkeley Eyewear Center * Having eye conditions or diseases that could potentially cause a decrease in visual acuity over the course of participation in the study * Having eye conditions or diseases that could potentially interfere with ability to use Test and Control spectacles as primary form of presbyopia correction

Design outcomes

Primary

MeasureTime frameDescription
Visual Acuity, High Contrast, Distance ChartPost-1 week of wear of Test Spectacles and post-1 week of wear of Control SpectaclesStandard assessment of high contrast visual acuity at distance, as in normal clinical practice, using Baily-Lovey charts and the M&S Technologies Smart System II visual acuity projection system.
Visual Acuity, Low Contrast, Distance ChartPost-1 week of wear of Test Spectacles and post-1 week of wear of Control SpectaclesStandard assessment of low contrast visual acuity at distance, as in normal clinical practice, using Baily-Lovey charts and the M&S Technologies Smart System II visual acuity projection system.
Visual Acuity, High Contrast, Near ChartPost-1 week of wear of Test Spectacles and post-1 week of wear of Control SpectaclesStandard assessment of high contrast visual acuity at near, as in normal clinical practice, using Baily-Lovey charts and the M&S Technologies Smart System II visual acuity projection system.
Visual Acuity, Low Contrast, Near ChartPost-1 week of wear of Test Spectacles and post-1 week of wear of Control SpectaclesStandard assessment of low contrast visual acuity at near, as in normal clinical practice, using Baily-Lovey charts and the M&S Technologies Smart System II visual acuity projection system.
30-degree Off-axis Distance Visual Acuity, High Contrast ChartPost-1 week of wear of Test Spectacles and post-1 week of wear of Control SpectaclesMeasured with subject immobilized in specially designed apparatus, keeping head pointed straight forward and moving only the eyes to left or right to view the off-axis chart
30-degree Off-axis Distance Visual Acuity, Low Contrast ChartPost-1 week of wear of Test Spectacles and post-1 week of wear of Control SpectaclesMeasured with subject immobilized in specially designed apparatus, keeping head pointed straight forward and moving only the eyes to left or right to view the off-axis chart
Horizontal Extent of Undistorted Vision at Reading DistancePost-1 week of wear of Test Spectacles and post-1 week of wear of Control SpectaclesNovel apparatus designed to immobilize head and allow subject to indicate point of peripheral optical distortion on a modified Amsler-type grid
Questionnaire BatteryAt study exit, after both Test and Control spectacles had been worn for 1 week eachForced-choice Likert scale preference questionnaire

Countries

United States

Participant flow

Recruitment details

Presbyopic subjects were recruited from the population of patients who were purchasing non-free-form PAL spectacles with antireflective coating in new frames from the University of California, Berkeley School of Optometry Eyewear Center.

Pre-assignment details

95 subjects were recruited, all of whom met the eligibility criteria and completed the study.

Participants by arm

ArmCount
All Study Participants
Crossover trial: all study participants received both Test and Control spectacles, in randomized order.
95
Total95

Baseline characteristics

CharacteristicAll Study Participants
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
15 Participants
Age, Categorical
Between 18 and 65 years
80 Participants
Age, Continuous58.1 years
STANDARD_DEVIATION 6.5
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
Race (NIH/OMB)
Asian
12 Participants
Race (NIH/OMB)
Black or African American
3 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
6 Participants
Race (NIH/OMB)
White
73 Participants
Region of Enrollment
United States
95 participants
Sex: Female, Male
Female
57 Participants
Sex: Female, Male
Male
38 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 950 / 95
other
Total, other adverse events
0 / 950 / 95
serious
Total, serious adverse events
0 / 950 / 95

Outcome results

Primary

30-degree Off-axis Distance Visual Acuity, High Contrast Chart

Measured with subject immobilized in specially designed apparatus, keeping head pointed straight forward and moving only the eyes to left or right to view the off-axis chart

Time frame: Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles

Population: 95 presbyopic subjects wearing standard, non-free-form, non-customized PAL spectacles for 1 week, and individually customized, free-form surfaced PAL spectacles for 1 week, in randomized order, with a 1-week washout period

ArmMeasureGroupValue (MEAN)Dispersion
Control Spectacles30-degree Off-axis Distance Visual Acuity, High Contrast ChartOff-Axis Left0.10 logMARStandard Deviation 0.13
Control Spectacles30-degree Off-axis Distance Visual Acuity, High Contrast ChartOff-Axis Right0.05 logMARStandard Deviation 0.09
Test Spectacles30-degree Off-axis Distance Visual Acuity, High Contrast ChartOff-Axis Left0.10 logMARStandard Deviation 0.14
Test Spectacles30-degree Off-axis Distance Visual Acuity, High Contrast ChartOff-Axis Right0.04 logMARStandard Deviation 0.1
Primary

30-degree Off-axis Distance Visual Acuity, Low Contrast Chart

Measured with subject immobilized in specially designed apparatus, keeping head pointed straight forward and moving only the eyes to left or right to view the off-axis chart

Time frame: Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles

Population: 95 presbyopic subjects wearing standard, non-free-form, non-customized PAL spectacles for 1 week, and individually customized, free-form surfaced PAL spectacles for 1 week, in randomized order, with a 1-week washout period

ArmMeasureGroupValue (MEAN)Dispersion
Control Spectacles30-degree Off-axis Distance Visual Acuity, Low Contrast ChartOff-Axis Left0.24 logMARStandard Deviation 0.12
Control Spectacles30-degree Off-axis Distance Visual Acuity, Low Contrast ChartOff-Axis Right0.19 logMARStandard Deviation 0.1
Test Spectacles30-degree Off-axis Distance Visual Acuity, Low Contrast ChartOff-Axis Left0.24 logMARStandard Deviation 0.12
Test Spectacles30-degree Off-axis Distance Visual Acuity, Low Contrast ChartOff-Axis Right0.16 logMARStandard Deviation 0.11
Primary

Horizontal Extent of Undistorted Vision at Reading Distance

Novel apparatus designed to immobilize head and allow subject to indicate point of peripheral optical distortion on a modified Amsler-type grid

Time frame: Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles

Population: 95 presbyopic subjects wearing standard, non-free-form, non-customized PAL spectacles for 1 week, and individually customized, free-form surfaced PAL spectacles for 1 week, in randomized order, with a 1-week washout period

ArmMeasureValue (MEAN)Dispersion
Control SpectaclesHorizontal Extent of Undistorted Vision at Reading Distance17.74 cmStandard Deviation 9.87
Test SpectaclesHorizontal Extent of Undistorted Vision at Reading Distance20.06 cmStandard Deviation 11.89
Primary

Questionnaire Battery

Forced-choice Likert scale preference questionnaire

Time frame: At study exit, after both Test and Control spectacles had been worn for 1 week each

Population: 95 presbyopic subjects wearing standard, non-free-form, non-customized PAL spectacles for 1 week, and individually customized, free-form surfaced PAL spectacles for 1 week, in randomized order, with a 1-week washout period

ArmMeasureGroupValue (NUMBER)
Control SpectaclesQuestionnaire BatteryPreference for Distance Vision40 percentage of participants
Control SpectaclesQuestionnaire BatteryOverall Preference45 percentage of participants
Control SpectaclesQuestionnaire BatteryPreference for Active Vision40 percentage of participants
Control SpectaclesQuestionnaire BatteryPreference for Midrange Vision45 percentage of participants
Control SpectaclesQuestionnaire BatteryPreference for Transitional Vision45 percentage of participants
Control SpectaclesQuestionnaire BatteryPreference for Near Vision50 percentage of participants
Test SpectaclesQuestionnaire BatteryPreference for Transitional Vision55 percentage of participants
Test SpectaclesQuestionnaire BatteryPreference for Midrange Vision55 percentage of participants
Test SpectaclesQuestionnaire BatteryOverall Preference55 percentage of participants
Test SpectaclesQuestionnaire BatteryPreference for Distance Vision60 percentage of participants
Test SpectaclesQuestionnaire BatteryPreference for Near Vision50 percentage of participants
Test SpectaclesQuestionnaire BatteryPreference for Active Vision60 percentage of participants
Primary

Visual Acuity, High Contrast, Distance Chart

Standard assessment of high contrast visual acuity at distance, as in normal clinical practice, using Baily-Lovey charts and the M&S Technologies Smart System II visual acuity projection system.

Time frame: Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles

Population: 95 presbyopic subjects wearing standard, non-free-form, non-customized PAL spectacles for 1 week, and individually customized, free-form surfaced PAL spectacles for 1 week, in randomized order, with a 1-week washout period

ArmMeasureValue (MEAN)Dispersion
Control SpectaclesVisual Acuity, High Contrast, Distance Chart-0.12 logMARStandard Deviation 0.06
Test SpectaclesVisual Acuity, High Contrast, Distance Chart-0.11 logMARStandard Deviation 0.07
Primary

Visual Acuity, High Contrast, Near Chart

Standard assessment of high contrast visual acuity at near, as in normal clinical practice, using Baily-Lovey charts and the M&S Technologies Smart System II visual acuity projection system.

Time frame: Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles

Population: 95 presbyopic subjects wearing standard, non-free-form, non-customized PAL spectacles for 1 week, and individually customized, free-form surfaced PAL spectacles for 1 week, in randomized order, with a 1-week washout period

ArmMeasureValue (MEAN)Dispersion
Control SpectaclesVisual Acuity, High Contrast, Near Chart-0.11 logMARStandard Deviation 0.13
Test SpectaclesVisual Acuity, High Contrast, Near Chart-0.09 logMARStandard Deviation 0.09
Primary

Visual Acuity, Low Contrast, Distance Chart

Standard assessment of low contrast visual acuity at distance, as in normal clinical practice, using Baily-Lovey charts and the M&S Technologies Smart System II visual acuity projection system.

Time frame: Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles

Population: 95 presbyopic subjects wearing standard, non-free-form, non-customized PAL spectacles for 1 week, and individually customized, free-form surfaced PAL spectacles for 1 week, in randomized order, with a 1-week washout period

ArmMeasureValue (MEAN)Dispersion
Control SpectaclesVisual Acuity, Low Contrast, Distance Chart0.01 logMARStandard Deviation 0.07
Test SpectaclesVisual Acuity, Low Contrast, Distance Chart0.01 logMARStandard Deviation 0.07
Primary

Visual Acuity, Low Contrast, Near Chart

Standard assessment of low contrast visual acuity at near, as in normal clinical practice, using Baily-Lovey charts and the M&S Technologies Smart System II visual acuity projection system.

Time frame: Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles

Population: 95 presbyopic subjects wearing standard, non-free-form, non-customized PAL spectacles for 1 week, and individually customized, free-form surfaced PAL spectacles for 1 week, in randomized order, with a 1-week washout period

ArmMeasureValue (MEAN)Dispersion
Control SpectaclesVisual Acuity, Low Contrast, Near Chart0.05 logMARStandard Deviation 0.09
Test SpectaclesVisual Acuity, Low Contrast, Near Chart0.12 logMARStandard Deviation 0.64

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026